Altimmune, Inc.
ALT
$7.03
$0.253.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.58M | -23.18M | -22.85M | -24.64M | -24.39M |
| Total Depreciation and Amortization | 29.00K | 33.00K | 37.00K | 61.00K | 107.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.31M | 2.42M | 2.09M | 3.32M | 2.68M |
| Change in Net Operating Assets | -608.00K | 2.46M | -6.40M | 3.16M | 5.26M |
| Cash from Operations | -16.84M | -18.27M | -27.12M | -18.11M | -16.36M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.10M | 13.63M | 1.20M | -3.70M | -39.52M |
| Cash from Investing | -5.10M | 13.63M | 1.20M | -3.70M | -39.52M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 34.92M | 10.09M | 270.00K | 198.00K | 339.00K |
| Repurchase of Common Stock | -678.00K | -2.00K | -4.00K | -244.00K | -600.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -125.00K | -- | -- | -- | -- |
| Cash from Financing | 34.12M | 10.09M | 266.00K | -46.00K | -261.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.18M | 5.45M | -25.65M | -21.85M | -56.14M |